{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:00:20Z","timestamp":1793919620565,"version":"4.8.0"},"reference-count":23,"publisher":"MDPI AG","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Results of recent studies suggest that high levels of endogenous testosterone decrease the risk of diabetes. Testosterone therapy may delay the transition from prediabetes to diabetes and accelerate healing of diabetic foot ulcers in hypogonadal men. We investigated whether testosterone therapy in this population decreases the occurrence of diabetic foot complications within 1 and 5 years of diabetes diagnosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Optum\u2019s deidentified Clinformatics Data Mart database was searched for male patients with diabetes. Associations between testosterone therapy and the occurrence of ulceration or the use of wound care were explored in the entire population and in those with and without hypogonadism using both bivariate and multivariate analyses.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Contrary to the hypotheses, testosterone therapy seems to confer increased risk of diabetic foot complications. In hypogonadal men with at least 1 year of follow-up after diabetes diagnosis, any use of testosterone therapy increased the odds of wound care utilization by a factor of 1.10 (95% confidence interval, 1.03\u20131.17), and the odds of ulceration by a factor of 1.13 (95% confidence interval, 1.03\u20131.24). Similar results are seen in all men, both with and without hypogonadism. Further exploration reveals that hypogonadism also increases the risk of wounds among people with diabetes with care utilization in the entire population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Further research is needed to elucidate the mechanisms by which hypogonadism and testosterone therapy impact diabetic foot complications, and whether these mechanisms are mediated by vascular or neurologic factors.\n                  <\/jats:p>","DOI":"10.7547\/22-112","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:59:25Z","timestamp":1731574765000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects of Hypogonadism and Testosterone Therapy on Diabetic Foot Complications"],"prefix":"10.3390","volume":"114","author":[{"given":"Daniel C.","family":"Jupiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli L.","family":"Faaitiiti","sequence":"additional","affiliation":[{"name":"John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Polychronopoulou","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Population Health, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"B1","article-title":"National Diabetes Statistics Report","year":"2020","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report. Atlanta, GA: US Department of Health and Human Services; 2020."},{"key":"B2","series-title":"Front Endocrinol (Lausanne)","first-page":"929","article-title":"New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine","volume":"10","author":"Yang H","year":"2019","unstructured":"Yang H, Sloan G, Ye Y, et al: New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol (Lausanne) 10: 929, 2019."},{"key":"B3","series-title":"Nat Rev Dis Primers","first-page":"42","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman EL","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, et al: Diabetic neuropathy. Nat Rev Dis Primers 5: 42, 2019."},{"key":"B4","series-title":"Int Wound J","first-page":"892","article-title":"The impact of foot ulceration and amputation on mortality in diabetic patients: I. From ulceration to death, a systematic review","volume":"13","author":"Jupiter DC","year":"2016","unstructured":"Jupiter DC, Thorud JC, Buckley CJ, et al: The impact of foot ulceration and amputation on mortality in diabetic patients: I. From ulceration to death, a systematic review. Int Wound J 13: 892, 2016."},{"key":"B5","series-title":"Diabet Med","first-page":"1493","article-title":"Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom","volume":"33","author":"Walsh JW","year":"2016","unstructured":"Walsh JW, Hoffstad OJ, Sullivan MO, et al: Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med 33: 1493, 2016."},{"key":"B6","series-title":"N Engl J Med","first-page":"2367","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong DG","year":"2017","unstructured":"Armstrong DG, Boulton AJM, Bus SA: Diabetic foot ulcers and their recurrence. N Engl J Med 376: 2367, 2017."},{"key":"B7","series-title":"Diabetes Care","first-page":"1033","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","year":"2013","unstructured":"American Diabetes Association: Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36: 1033, 2013."},{"key":"B8","series-title":"Diabetes Care","first-page":"1609","article-title":"Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions","volume":"42","author":"O\u2019Connell JM","year":"2019","unstructured":"O\u2019Connell JM, Manson SM: Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions. Diabetes Care 42: 1609, 2019."},{"key":"B9","series-title":"StatPearls [Internet]","article-title":"Diabetic Foot Ulcer","author":"Oliver TI","year":"2020","unstructured":"Oliver TI, Mutluoglu M: \u201cDiabetic Foot Ulcer,\u201d in StatPearls [Internet], StatPearls Publishing, Treasure Island, FL, 2020."},{"key":"B10","series-title":"Diabetes Care","first-page":"2409","article-title":"Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients","volume":"29","author":"Chen HF","year":"2006","unstructured":"Chen HF, Ho CA, Li CY: Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 29: 2409, 2006."},{"key":"B11","series-title":"Curr Urol Rep","first-page":"467","article-title":"Testosterone, diabetes mellitus, and the metabolic syndrome","volume":"8","author":"Spark RF","year":"2007","unstructured":"Spark RF: Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep 8: 467, 2007."},{"key":"B12","series-title":"Diabetes Care","first-page":"1104","article-title":"Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study","volume":"42","author":"Yassin A","year":"2019","unstructured":"Yassin A, Haider A, Haider KS, et al: Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study. Diabetes Care 42: 1104, 2019."},{"key":"B13","series-title":"J Clin Endocrinol Metab","first-page":"4335","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann M","year":"2006","unstructured":"Zitzmann M, Faber S, Nieschlag E: Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91: 4335, 2006."},{"key":"B14","series-title":"J Clin Endocrinol Metab","first-page":"2536","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin S","year":"2010","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, et al: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536, 2010."},{"key":"B15","series-title":"Cardiovasc Diabetol","first-page":"19","article-title":"Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease: report of three cases","volume":"8","author":"Kalinchenko S","year":"2009","unstructured":"Kalinchenko S, Zemlyanoy A, Gooren LJ: Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease: report of three cases. Cardiovasc Diabetol 8: 19, 2009."},{"key":"B16","series-title":"Clin Endocrinol (Oxf)","first-page":"885","article-title":"Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database","volume":"91","author":"Lopez DS","year":"2019","unstructured":"Lopez DS, Huang D, Tsilidis KK, et al: Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf) 91: 885, 2019."},{"key":"B17","series-title":"JAMA Intern Med","first-page":"491","article-title":"Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency","volume":"177","author":"Cheetham TC","year":"2017","unstructured":"Cheetham TC, An J, Jacobsen SJ, et al: Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency. JAMA Intern Med 177: 491, 2017."},{"key":"B18","series-title":"JAMA Intern Med","first-page":"459","article-title":"Further elucidation of the potential benefits of testosterone therapy in older men","volume":"177","author":"Orwoll E","year":"2017","unstructured":"Orwoll E: Further elucidation of the potential benefits of testosterone therapy in older men. JAMA Intern Med 177: 459, 2017."},{"key":"B19","series-title":"Methodist Debakey Cardiovasc J","first-page":"68","article-title":"Testosterone and the heart","volume":"13","author":"Goodale T","year":"2017","unstructured":"Goodale T, Sadhu A, Petak S, et al: Testosterone and the heart. Methodist Debakey Cardiovasc J 13: 68, 2017."},{"key":"B20","series-title":"J Am Coll Cardiol","first-page":"545","article-title":"Testosterone and cardiovascular disease","volume":"67","author":"Kloner RA","year":"2016","unstructured":"Kloner RA, Carson C III, Dobs A, et al: Testosterone and cardiovascular disease. J Am Coll Cardiol 67: 545, 2016."},{"key":"B21","series-title":"Clin Endocrinol (Oxf)","first-page":"602","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko SY","year":"2010","unstructured":"Kalinchenko SY, Tishova YA, Mskhalaya GJ, et al: Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73: 602, 2010."},{"key":"B22","series-title":"J Am Coll Cardiol","first-page":"2555","article-title":"Endogenous sex hormones and incident cardiovascular disease in post-menopausal women","volume":"71","author":"Zhao D","year":"2018","unstructured":"Zhao D, Guallar E, Ouyang P, et al: Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol 71: 2555, 2018."},{"key":"B23","series-title":"Andrology","first-page":"919","article-title":"Association between endogenous sex steroid hormones and inflammatory biomarkers in US men","volume":"1","author":"Tsilidis KK","year":"2013","unstructured":"Tsilidis KK, Rohrmann S, McGlynn KA, et al: Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology 1: 919, 2013."}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/114\/5\/22-112.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/114\/5\/22-112.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/114\/5\/22-112.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:19:50Z","timestamp":1783505990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/114\/5\/22112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.7547\/22-112","relation":{},"ISSN":["8750-7315"],"issn-type":[{"value":"8750-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}